Clinical Trials Directory

Trials / Completed

CompletedNCT03196596

Added Value of Patient-specific Computer Simulation in Transcatheter Aortic Valve Implantation (TAVI)

The Value of Patient-specific Computer Simulation in the Planning of TAVI With the Self-expanding Evolut R Valve

Status
Completed
Phase
Study type
Observational
Enrollment
80 (actual)
Sponsor
Erasmus Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Transcatheter aortic valve implantation is increasingly used to treat patients with severe aortic stenosis who are at increased risk for surgical aortic valve replacement and is projected to be the preferred treatment modality. As patient selection and operator experience have improved, it is hypothesised that device-host interactions will play a more dominant role in outcome. This, in combination with the increasing number of valve types and sizes, confronts the physician with the dilemma to choose the valve that best fits the individual patient. This necessitates the availability of pre-procedural computer simulation that is based upon the integration of the patient-specific anatomy, the physical and (bio)mechanical properties of the valve and recipient anatomy derived from in-vitro experiments. Patient-specific computer simulation may improve outcome of TAVI by proposing the valve size that best fits the individual patient. The aim of this study is to assess the added value of patient-specific computer simulation in valve size selection.

Conditions

Interventions

TypeNameDescription
OTHERComputer simulationIn these patients, a computer simulation model will be obtained based on pre procedural CT

Timeline

Start date
2017-05-23
Primary completion
2019-01-08
Completion
2019-01-31
First posted
2017-06-23
Last updated
2019-02-06

Locations

5 sites across 5 countries: Belgium, Denmark, Germany, Italy, Netherlands

Source: ClinicalTrials.gov record NCT03196596. Inclusion in this directory is not an endorsement.